We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Liver Resection Promotes Long-Term Survival

By HospiMedica International staff writers
Posted on 10 Mar 2015
A new study shows that in situ split (ISS) liver resection can provide long-term survival for patients with advanced liver malignancies.

Researchers at University Hospital Regensburg (Germany) conducted a study that retrospectively analyzed 16 patients who underwent ISS liver resection between 2007 and 2014. The procedure involves a novel method to induce rapid hypertrophy of the contra-lateral liver lobe, and is intended for patients at risk of postoperative liver failure due to an insufficient amount of liver tissue remaining after the resection. Two patients were lost in early postoperative phase (90 days), and one was lost during follow-up.

Of the remaining 13 patients with a follow-up period of more than 3 months, seven suffered from colorectal liver metastases (CRLM), and six from various other liver malignancies (non-CRLM). The ISS procedure resulted in a median increase of 86.3% of the left lateral liver lobe after a median time period of nine days. The median disease-free survival (DFS) time was 14.6 months, and the median overall survival was 41.7 months (reduced to 26.4 months when including 90-days mortality). The three-year survival rate was 64.3% for the CRLM and 50% for the non-CRLM patients. The study was published in the February 2015 issue of Langenbeck's Archives of Surgery.

“We retrospectively analyzed our patients treated with ISS liver resection at the department of surgery of the University of Regensburg, the first center worldwide to perform ISS,” concluded lead author Sven Lang, MD, and colleagues. “ISS liver resection can provide long-term survival of selected patients with advanced liver malignancies that otherwise are not eligible for liver resection due to insufficient liver remnant.”

ISS, also known as associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) combines portal vein ligation and complete parenchymal transaction, splitting the lobe along the right side of the falciform ligament. After a median of nine days, the segments increase by about 75%, allowing for the subsequent hepatectomy.

Related Links:

University Hospital Regensburg



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Computerized Spirometer
DatospirAira

Latest Surgical Techniques News

Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing

Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery

Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions